Policy & Law

Why Not the Best? Or, at Least, Why Not the Same?

1 Mins read

The U.S. Medicaid program is likely paying far more than necessary for medications and not offering patients the most effective ones available, by ignoring international evidence-based lists of safe and effective medications, according to a new study by researchers at UCSF.

The U.S. Medicaid program is likely paying far more than necessary for medications and not offering patients the most effective ones available, by ignoring international evidence-based lists of safe and effective medications, according to a new study by researchers at UCSF.

“The United States has 51 different lists of medications that are paid for by Medicaid, and only a third of those medications consistently appear on the various lists,” said Lisa A. Bero, PhD, a professor in the UCSF School of Pharmacy. “This research suggests that Medicaid could save significant money and also provide safer and more effective medications for patients by using a more consistent approach to deciding which drugs will be covered.”

Full article on how the U.S. Medicaid program is ignoring international, evidence-based lists of safe and effective medications.

   

Related posts
Global HealthcarePolicy & Law

5 Tactics for Safeguarding the Global Health Industry Post-Covid-19

2 Mins read
We are beginning to enter into a new era in the fight against Covid-19, but there is yet more work to be…
Health carePolicy & Law

Three Tips for Improving Your Posture

2 Mins read
Posture is indicative of a number of things. Some importance, perhaps too much, is placed on body language. How standing and sitting…
Health carePolicy & Law

What happens when an inmate goes to the hospital?

2 Mins read
Healthcare is an important aspect of prisoner welfare in the US and indeed those who are incarcerated have a right to receive…